Arctic Bioscience (Norway) Today
| ABS Stock | NOK 2.06 0.04 1.98% |
Performance0 of 100
| Odds Of DistressOver 65
|
Arctic Bioscience is selling for 2.06 as of the 11th of December 2024. This is a 1.98 percent up since the beginning of the trading day. The stock's lowest day price was 1.95. Arctic Bioscience has more than 65 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 12th of September 2024 and ending today, the 11th of December 2024. Click here to learn more.
Arctic Bioscience AS, a biotechnology company, provides nutraceutical and pharmaceutical products. Arctic Bioscience AS was incorporated in 2011 and is based in rsta, Norway. ARCTIC BIOSCIENCE is traded on Oslo Stock Exchange in Norway. The company has 24.38 M outstanding shares. More on Arctic Bioscience AS
Moving together with Arctic Stock
Moving against Arctic Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Arctic Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Arctic Bioscience's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Arctic Bioscience or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Arctic Bioscience AS (ABS) is traded on Oslo Stock Exchange in Norway and employs 13 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 276.66 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Arctic Bioscience's market, we take the total number of its shares issued and multiply it by Arctic Bioscience's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Arctic Bioscience operates under Healthcare sector and is part of Biotechnology industry. The entity has 24.38 M outstanding shares.
Arctic Bioscience generates negative cash flow from operations
Check Arctic Bioscience Probability Of Bankruptcy
Ownership AllocationArctic Bioscience holds a total of 24.38 Million outstanding shares. Arctic Bioscience AS retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Arctic Ownership Details
Arctic Bioscience Risk Profiles
Although Arctic Bioscience's alpha and beta are two of the key measurements used to evaluate Arctic Bioscience's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 7.33 | |||
| Standard Deviation | 13.99 | |||
| Variance | 195.8 | |||
| Risk Adjusted Performance | (0.06) |
Arctic Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Arctic Bioscience without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Price Transformation Now
Price TransformationUse Price Transformation models to analyze the depth of different equity instruments across global markets |
| All Next | Launch Module |
Arctic Bioscience Corporate Management
Elected by the shareholders, the Arctic Bioscience's board of directors comprises two types of representatives: Arctic Bioscience inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Arctic. The board's role is to monitor Arctic Bioscience's management team and ensure that shareholders' interests are well served. Arctic Bioscience's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Arctic Bioscience's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Steffen Eidal | VP Marketing | Profile | |
| Runhild Gammelster | Global Director | Profile | |
| Christer Valderhaug | Chief Officer | Profile | |
| Yuming Feng | Exec Devel | Profile | |
| Hogne Hallaraker | Founder Officer | Profile | |
| Jone Slinning | Chief Officer | Profile | |
| MBA MSc | CoFounder Chairman | Profile |
Other Information on Investing in Arctic Stock
Arctic Bioscience financial ratios help investors to determine whether Arctic Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Arctic with respect to the benefits of owning Arctic Bioscience security.